SCHEMBL5264558

SCHEMBL5264558

CCOC(=O)c1ccc(C(=O)OC)c(N)n1.CCOC(=O)c1ccc(C(=O)OCC)c(N)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.53
ALDH1A1 P00352 10/20 0.48
NPC1 O15118 7/20 0.48
SMN1; SMN2 Q16637 6/20 0.48
RAB9A P51151 6/20 0.48
MAPT P10636 4/20 0.48
TP53 P04637 1/20 0.48
LMNA P02545 2/20 0.47
HSD17B10 Q99714 5/20 0.46
KDM4E B2RXH2 4/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TSHR P16473 4/20 0.45
NFKB1 P19838 2/20 0.43
NFKB2 Q00653 2/20 0.43
RELA Q04206 2/20 0.43
MAPK1 P28482 1/20 0.43
RECQL P46063 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13853239 0.98 CYP1A2 (0.54) CYP1A2ALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL13853230 0.94 CYP1A2 (0.59) CYP1A2ALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL14956928 0.86 ALDH1A1 (0.47) ALDH1A1MAPTLMNAHSD17B10KDM4E
SCHEMBL13853237 0.85 CYP1A2 (0.56) CYP1A2ALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL27459666 0.85 ALDH1A1 (0.49) CYP1A2ALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL5262682 0.81 CYP1A2 (0.41) CYP1A2ALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL510572 0.80 ALDH1A1 (0.54) CYP1A2ALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL1680317 0.80 ALDH1A1 (0.54) CYP1A2ALDH1A1NPC1SMN1; SMN2RAB9A
SCHEMBL14967079 0.80 ALDH1A1 (0.45) ALDH1A1NPC1SMN1; SMN2RAB9AMAPT
SCHEMBL4192112 0.78 CYP1A2 (0.62) CYP1A2ALDH1A1NPC1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1824828-A2 PYRIDINE BASED COMPOUNDS USEFUL AS INTERMEDIATES FOR PHARMACEUTICAL OR AGRICULTURAL END-PRODUCTS Peakdale Molecular Limited (GB) 2007-08-29 EP disclosed
WO-2006059103-A2 PYRIDINE BASED COMPOUNDS USEFUL AS INTERMEDIATES FOR PHARMACEUTICAL OR AGRICULTURAL END-PRODUCTS PEAKDALE MOLECULAR LIMITED (GB) 2006-06-08 WO disclosed